The story does a nice job of highlighting the public policy implications of medical research findings. It reports not only the conclusions of a study calculating potential harms of a screening test for heart disease; it uses the new estimate of elevated cancer risk from CT screening to examine a Texas law that requires insurers to subsidize the scans. Rather than just tossing an isolated fact to readers, the reporter provides context that clearly shows how this information relates to the actions of legislators and the larger context of efforts to control the rising costs of health care – both financial costs and the potential health risks of tests and interventions.
The story not only mentions the cost of a scan to individuals ($100 to $500), it also notes that about $50 million dollars was spent on this type of scanning nationwide in 2008. A longer story could have also reported on the costs of additional testing and treatments triggered by screening apparently healthy individuals.
As mentioned above, the story notes that while some experts recommend CT screening for coronary artery calcium deposits in order to increase the number of people receiving treatment to reduce the likelihood of a heart, others are skeptical about the real value of this type of screening for apparently health people. The reporter points out that many heart attacks strike people who do not have very high cholesterol levels or other indicators of elevated risk, but also that “no study has linked the use of CT scans with better patient outcomes.”
The potential cancer risk caused by CT screening for signs of heart disease is the point of this story. Also, by highlighting uncertainty about the benefits of the screening and recapping debate over the Texas law mandating coverage of the scans, the story emphasizes the importance of considering potential harms when setting public policy on screening tests. A longer story could have considered other potential harms, including the side effects of treatments prescribed based on screening tests.
The story does a good job of summarizing the results of this study of potential cancer risk from CT screening. In addition, it outlines the positions of experts and organizations on the broader body of evidence on the use of CT scans to identify people who may have plaque buildups in their heart arteries.
It would have been better if the reporter stated that the estimate was based on several assumptions, that it wasn’t a definitive point estimate, but just the center of a range, and that it was higher than earlier estimates. Readers still got the point that there is a cancer risk which needs to be considered.
The story notes that heart disease is the leading cause of death in the U.S., but it also points out doubts about whether screening with CT scans for calcium buildup in heart arteries can reduce the toll.
The story includes experts and advocates that represent the key perspectives in debate about CT screening for calcium deposits in coronary arteries. However, it does not include information on possible conflicts of interest.
Although this story points out that alternative screening techniques are available and it makes reference to cholesterol, it does not include any details about the alternatives.
The story says that the CT scanners used for this test are “all over the city” and included an estimate that in 2008 about 200,000 people around the country were scanned for calcium buildups in their coronary arteries.
not in question in this story
The story includes quotes from independent experts and other information that was not in the news release about the journal article.
Systematic, Criteria-Driven
Puleeeeease... this 'game changer' weight loss drug causes more nausea and vomiting than a placebo. Some game, some change. My friend Gary would spank you for using the eighth word medical reporters should never, ever use. @garyschwitzer @thackerpd
https://www.healthnewsreview.org/toolkit/just-journalists-writing-tips-case-studies/7-words-and-more-you-shouldnt-use-in-medical-news/ https://twitter.com/OttawaCitizen/status/1361426796126830597
A scary @statnews Op-Ed warns that govt attempts to rein in Pharma may cut off access to "life-changing" drugs.
It takes @garyschwitzer to let us know: the author spent 10 years as Pfizer's public-policy chief. https://twitter.com/garyschwitzer/status/1360325022578053123
.@TranspariMED criticizes STAT op-ed for not disclosing pharma funding of author’s institute - similar to criticism we’ve made of STAT op-eds in the past. @transparify @ThinkTankWatch @icer_review https://www.healthnewsreview.org/2021/02/transparency-watchdog-criticizes-stats-non-disclosure-on-pro-pharma-op-ed/
Comments
Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.
Our Comments Policy
But before leaving a comment, please review these notes about our policy.
You are responsible for any comments you leave on this site.
This site is primarily a forum for discussion about the quality (or lack thereof) in journalism or other media messages (advertising, marketing, public relations, medical journals, etc.) It is not intended to be a forum for definitive discussions about medicine or science.
We will delete comments that include personal attacks, unfounded allegations, unverified claims, product pitches, profanity or any from anyone who does not list a full name and a functioning email address. We will also end any thread of repetitive comments. We don”t give medical advice so we won”t respond to questions asking for it.
We don”t have sufficient staffing to contact each commenter who left such a message. If you have a question about why your comment was edited or removed, you can email us at feedback@healthnewsreview.org.
There has been a recent burst of attention to troubles with many comments left on science and science news/communication websites. Read “Online science comments: trolls, trash and treasure.”
The authors of the Retraction Watch comments policy urge commenters:
We”re also concerned about anonymous comments. We ask that all commenters leave their full name and provide an actual email address in case we feel we need to contact them. We may delete any comment left by someone who does not leave their name and a legitimate email address.
And, as noted, product pitches of any sort – pushing treatments, tests, products, procedures, physicians, medical centers, books, websites – are likely to be deleted. We don”t accept advertising on this site and are not going to give it away free.
The ability to leave comments expires after a certain period of time. So you may find that you’re unable to leave a comment on an article that is more than a few months old.
You might also like